On day 1, GLP-1 was infused to stimulate endogenous insulin release and suppress endogenous glucagon. On days 2–5, pancreatic endocrine clamps were performed using somatostatin infusions of ...
Hosted on MSN4mon
New treatment strategy targets somatostatin to prevent blood sugar drops in type 1 diabetesalpha cells that release glucagon, beta cells that release insulin and delta cells that release somatostatin. The results provide an underlying explanation for how the reduced proportion of ...
This article will review the function of insulin, glucagon, and somatostatin, pathophysiology of hyperinsulinism, clinical manifestations, differential diagnosis, management, and reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback